Medlab Clinical Limited [ASX:MDC] share price and news 2022

Company Description

Medlab Clinical Limited (MDC) is a medical life science company, developing therapeutic pathways for diagnosed chronic diseases. Company has two main areas of operational focus: Pharmaceutical research and commercialisation (Pharmaceutical portfolio) and Development and sales of nutraceuticals product (Nutraceutical portfolio).

Medlab Clinical Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.medlab.co.

This a small cap company with market cap of 83 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 7.09 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how mdc dividend grows in the recent years.

No data